Literature DB >> 11694548

Clinical heterogeneity in lymphoedema-distichiasis with FOXC2 truncating mutations.

R P Erickson1, S L Dagenais, M S Caulder, C A Downs, G Herman, M C Jones, W S Kerstjens-Frederikse, A C Lidral, M McDonald, C C Nelson, M Witte, T W Glover.   

Abstract

BACKGROUND: Hereditary lymphoedema-distichiasis (LD) is an autosomal dominant disorder that classically presents as lymphoedema of the limbs, with variable age of onset, and extra aberrant growth of eyelashes from the Meibomian gland (distichiasis). Other major reported complications include cardiac defects, cleft palate, and extradural cysts. Photophobia, exotropia, ptosis, congenital ectropion, and congenital cataracts are additional eye findings. Recently, we reported that truncating mutations in the forkhead transcription family member FOXC2 resulted in LD in two families.
METHODS: The clinical findings in seven additional families with LD, including the original family described by Falls and Kertesz, were determined and mutational analyses were performed.
RESULTS: Distichiasis was the most common clinical feature followed by age dependent lymphoedema. There is a wide variation of associated secondary features including tetralogy of Fallot and cleft palate. The mutational analyses identified truncating mutations in all of the families studied (two nonsense, one deletion, three insertion, and one insertion-deletion), which most likely result in haploinsufficiency of FOXC2.
CONCLUSIONS: FOXC2 mutations are highly penetrant with variable expressivity which is not explicable by the pattern of mutations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11694548      PMCID: PMC1734771          DOI: 10.1136/jmg.38.11.761

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  24 in total

1.  Analyses of the effects that disease-causing missense mutations have on the structure and function of the winged-helix protein FOXC1.

Authors:  R A Saleem; S Banerjee-Basu; F B Berry; A D Baxevanis; M A Walter
Journal:  Am J Hum Genet       Date:  2001-03       Impact factor: 11.025

2.  Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema.

Authors:  M J Karkkainen; R E Ferrell; E C Lawrence; M A Kimak; K L Levinson; M A McTigue; K Alitalo; D N Finegold
Journal:  Nat Genet       Date:  2000-06       Impact factor: 38.330

3.  A NEW SYNDROME COMBINING PTERYGIUM COLLI WITH DEVELOPMENTAL ANOMALIES OF THE EYELIDS AND LYMPHATICS OF THE LOWER EXTREMITIES.

Authors:  H F FALLS; E D KERTESZ
Journal:  Trans Am Ophthalmol Soc       Date:  1964

4.  Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase.

Authors:  A Irrthum; M J Karkkainen; K Devriendt; K Alitalo; M Vikkula
Journal:  Am J Hum Genet       Date:  2000-06-09       Impact factor: 11.025

5.  Distichiasis-lymphedema. A hereditary syndrome of multiple congenital defects.

Authors:  M Robinow; G F Johnson; A D Verhagen
Journal:  Am J Dis Child       Date:  1970-04

6.  Vascular endothelial growth factor (VEGF) and VEGF-C show overlapping binding sites in embryonic endothelia and distinct sites in differentiated adult endothelia.

Authors:  A Lymboussaki; B Olofsson; U Eriksson; K Alitalo
Journal:  Circ Res       Date:  1999-11-26       Impact factor: 17.367

7.  Truncating mutations in FOXC2 cause multiple lymphedema syndromes.

Authors:  D N Finegold; M A Kimak; E C Lawrence; K L Levinson; E M Cherniske; B R Pober; J W Dunlap; R E Ferrell
Journal:  Hum Mol Genet       Date:  2001-05-15       Impact factor: 6.150

8.  Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome.

Authors:  J Fang; S L Dagenais; R P Erickson; M F Arlt; M W Glynn; J L Gorski; L H Seaver; T W Glover
Journal:  Am J Hum Genet       Date:  2000-11-08       Impact factor: 11.025

9.  VEGF-D promotes the metastatic spread of tumor cells via the lymphatics.

Authors:  S A Stacker; C Caesar; M E Baldwin; G E Thornton; R A Williams; R Prevo; D G Jackson; S Nishikawa; H Kubo; M G Achen
Journal:  Nat Med       Date:  2001-02       Impact factor: 53.440

10.  Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3.

Authors:  T Mäkinen; L Jussila; T Veikkola; T Karpanen; M I Kettunen; K J Pulkkanen; R Kauppinen; D G Jackson; H Kubo; S Nishikawa; S Ylä-Herttuala; K Alitalo
Journal:  Nat Med       Date:  2001-02       Impact factor: 53.440

View more
  22 in total

Review 1.  The new era of the lymphatic system: no longer secondary to the blood vascular system.

Authors:  Inho Choi; Sunju Lee; Young-Kwon Hong
Journal:  Cold Spring Harb Perspect Med       Date:  2012-04       Impact factor: 6.915

2.  Microcephaly, intellectual impairment, bilateral vesicoureteral reflux, distichiasis, and glomuvenous malformations associated with a 16q24.3 contiguous gene deletion and a Glomulin mutation.

Authors:  Matthew G Butler; Susan L Dagenais; José L Garcia-Perez; Pascal Brouillard; Miikka Vikkula; Peter Strouse; Jeffrey W Innis; Thomas W Glover
Journal:  Am J Med Genet A       Date:  2012-03-09       Impact factor: 2.802

3.  Linkage to the FOXC2 region of chromosome 16 for varicose veins in otherwise healthy, unselected sibling pairs.

Authors:  M Y M Ng; T Andrew; T D Spector; S Jeffery
Journal:  J Med Genet       Date:  2005-03       Impact factor: 6.318

4.  Lymphoedema-distichiasis and FOXC2: unreported mutations, de novo mutation estimate, families without coding mutations.

Authors:  Carolyn Sholto-Douglas-Vernon; Rachel Bell; Glen Brice; Sahar Mansour; Mansoor Sarfarazi; Anne H Child; Alberto Smith; Russell Mellor; Kevin Burnand; Peter Mortimer; Steve Jeffery
Journal:  Hum Genet       Date:  2005-05-20       Impact factor: 4.132

5.  Linkage and sequence analysis indicate that CCBE1 is mutated in recessively inherited generalised lymphatic dysplasia.

Authors:  Fiona Connell; Kamini Kalidas; Pia Ostergaard; Glen Brice; Tessa Homfray; Lesley Roberts; David J Bunyan; Sally Mitton; Sahar Mansour; Peter Mortimer; Steve Jeffery
Journal:  Hum Genet       Date:  2009-11-13       Impact factor: 4.132

6.  Dysmorphogenesis of lymph nodes in Foxc2 haploinsufficient mice.

Authors:  Hiroshi Shimoda; Michael J Bernas; Marlys H Witte
Journal:  Histochem Cell Biol       Date:  2011-05-26       Impact factor: 4.304

Review 7.  Lymphatic development.

Authors:  Matthew G Butler; Sumio Isogai; Brant M Weinstein
Journal:  Birth Defects Res C Embryo Today       Date:  2009-09

8.  Analysis of the phenotypic abnormalities in lymphoedema-distichiasis syndrome in 74 patients with FOXC2 mutations or linkage to 16q24.

Authors:  G Brice; S Mansour; R Bell; J R O Collin; A H Child; A F Brady; M Sarfarazi; K G Burnand; S Jeffery; P Mortimer; V A Murday
Journal:  J Med Genet       Date:  2002-07       Impact factor: 6.318

Review 9.  Understanding lymphangiogenesis in knockout models, the cornea, and ocular diseases for the development of therapeutic interventions.

Authors:  Jessica F Yang; Amit Walia; Yu-hui Huang; Kyu-yeon Han; Mark I Rosenblatt; Dimitri T Azar; Jin-Hong Chang
Journal:  Surv Ophthalmol       Date:  2015-12-17       Impact factor: 6.048

Review 10.  Overlapping biomarkers, pathways, processes and syndromes in lymphatic development, growth and neoplasia.

Authors:  Marlys H Witte; Michael T Dellinger; Cristobal M Papendieck; Francesco Boccardo
Journal:  Clin Exp Metastasis       Date:  2012-07-15       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.